(Q54162418)
Statements
Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index (English)
Kristensen CA
Kristjansen PE
Brünner N
Quistorff B
Spang-Thomsen M
1 September 1995